Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Merck Sharp and Dohme (MISP ID 59252)
- License Information
-
More Information
Article History
Received: 19 May 2021
Accepted: 24 July 2021
First Online: 21 August 2021
Declarations
:
: The study was approved by the local ethics committee (EK 31–301 ex 18/19).
: The institutional review board of the Medical University of Graz approved all study procedures, the study protocol, and the informed-consent form for off-lable treatment with GLM. All patients and/or parents gave written informed consent.
: The authors declare that they have no competing interests.
